Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0YOLXT
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
HER2-ADC-013
|
|||||
| Synonyms |
HER2-ADC-013
Click to Show/Hide
|
|||||
| Organization |
Suzhou Medilink Therapeutics Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
0.9;4.7
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
DL012-payload
|
Payload Info | ||||
| Payload Name |
DL003-payload
|
Payload Info | ||||
| Linker Name |
DL012-Linker
|
Linker Info | ||||
| Linker Name |
DL003-Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
DL012;DL003
|
|||||